Global Glycobiology Market Report 2020-2025: Focus on Drug Discovery, Disease Diagnostics, Virology, Cell Biology, & Oncology
January 13, 2021 05:23 ET
|
Research and Markets
Dublin, Jan. 13, 2021 (GLOBE NEWSWIRE) -- The "Global Glycobiology Market, By Product (Enzymes, Instruments, Reagents and Kits), By Application (Drug Discovery, Disease Diagnostics, Virology, Cell...
GO Therapeutics appoints Dr. Robert J. Wills to Board of Directors
October 04, 2017 07:30 ET
|
GO Therapeutics
CAMBRIDGE, Mass., Oct. 04, 2017 (GLOBE NEWSWIRE) -- GO Therapeutics, a company exploiting new advances in glycoproteomics to develop novel, multimodal first-in-class cancer therapeutics against...
Salubris Pharmaceuticals Invests $5 Million in GO Therapeutics
September 25, 2017 12:06 ET
|
GO Therapeutics
CAMBRIDGE, Mass., Sept. 25, 2017 (GLOBE NEWSWIRE) -- GO Therapeutics today announced that Salubris Pharmaceutical Limited has made a $5M investment in GO Therapeutics, a Cambridge, MA-based company...
Glycomics Market (Glycobiology) 2019 Worldwide Forecasts in New Research Report
November 04, 2014 09:16 ET
|
ReportsnReports
DALLAS, Nov. 4, 2014 (GLOBE NEWSWIRE) -- The worldwide glycomics market (glycobiology) is expected to grow at 12.62% CAGR and reach $928.11 Million in 2019. The key drivers for this market are the...